A Clinical Rationale for Assessing the Impact of Childhood Sexual Abuse on Adjunctive Subcutaneous Esketamine for Treatment-Resistant Depression

Background: A history of child sexual abuse (CSA) is related to higher suicide rates and poor treatment outcomes in depressed adult patients. Twenty years after the first study investigating the effects of ketamine/esketamine on depression and suicide, there is a lack of data on the CSA effects on t...

Full description

Bibliographic Details
Main Authors: Eduardo Jorge Muniz Magalhães, Luciana Maria Sarin, Lorena Catarina Del Sant, Ana Cecília Lucchese, Carolina Nakahira, Marco Aurélio Tuena, Camila Brito Puertas, Victor Augusto Rodovalho Fava, Rodrigo Simonini Delfino, Juliana Surjan, Matheus Souza Steglich, Matheus Ghossain Barbosa, Guilherme Abdo, José Alberto Del Porto, Charles B. Nemeroff, Hugo Cogo-Moreira, Acioly Luiz Tavares Lacerda, Andrea Feijo Mello
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Psychiatry
Subjects:
sex
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2021.608499/full
id doaj-b9638f2dcfc5465186e6869dc8fd3f86
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Eduardo Jorge Muniz Magalhães
Luciana Maria Sarin
Lorena Catarina Del Sant
Ana Cecília Lucchese
Carolina Nakahira
Marco Aurélio Tuena
Camila Brito Puertas
Victor Augusto Rodovalho Fava
Rodrigo Simonini Delfino
Rodrigo Simonini Delfino
Juliana Surjan
Juliana Surjan
Matheus Souza Steglich
Matheus Souza Steglich
Matheus Ghossain Barbosa
Guilherme Abdo
José Alberto Del Porto
José Alberto Del Porto
Charles B. Nemeroff
Hugo Cogo-Moreira
Hugo Cogo-Moreira
Acioly Luiz Tavares Lacerda
Acioly Luiz Tavares Lacerda
Acioly Luiz Tavares Lacerda
Acioly Luiz Tavares Lacerda
Andrea Feijo Mello
Andrea Feijo Mello
spellingShingle Eduardo Jorge Muniz Magalhães
Luciana Maria Sarin
Lorena Catarina Del Sant
Ana Cecília Lucchese
Carolina Nakahira
Marco Aurélio Tuena
Camila Brito Puertas
Victor Augusto Rodovalho Fava
Rodrigo Simonini Delfino
Rodrigo Simonini Delfino
Juliana Surjan
Juliana Surjan
Matheus Souza Steglich
Matheus Souza Steglich
Matheus Ghossain Barbosa
Guilherme Abdo
José Alberto Del Porto
José Alberto Del Porto
Charles B. Nemeroff
Hugo Cogo-Moreira
Hugo Cogo-Moreira
Acioly Luiz Tavares Lacerda
Acioly Luiz Tavares Lacerda
Acioly Luiz Tavares Lacerda
Acioly Luiz Tavares Lacerda
Andrea Feijo Mello
Andrea Feijo Mello
A Clinical Rationale for Assessing the Impact of Childhood Sexual Abuse on Adjunctive Subcutaneous Esketamine for Treatment-Resistant Depression
Frontiers in Psychiatry
child sex abuse
treatment-resistant depression
esketamine
sex
directed acyclic graph
author_facet Eduardo Jorge Muniz Magalhães
Luciana Maria Sarin
Lorena Catarina Del Sant
Ana Cecília Lucchese
Carolina Nakahira
Marco Aurélio Tuena
Camila Brito Puertas
Victor Augusto Rodovalho Fava
Rodrigo Simonini Delfino
Rodrigo Simonini Delfino
Juliana Surjan
Juliana Surjan
Matheus Souza Steglich
Matheus Souza Steglich
Matheus Ghossain Barbosa
Guilherme Abdo
José Alberto Del Porto
José Alberto Del Porto
Charles B. Nemeroff
Hugo Cogo-Moreira
Hugo Cogo-Moreira
Acioly Luiz Tavares Lacerda
Acioly Luiz Tavares Lacerda
Acioly Luiz Tavares Lacerda
Acioly Luiz Tavares Lacerda
Andrea Feijo Mello
Andrea Feijo Mello
author_sort Eduardo Jorge Muniz Magalhães
title A Clinical Rationale for Assessing the Impact of Childhood Sexual Abuse on Adjunctive Subcutaneous Esketamine for Treatment-Resistant Depression
title_short A Clinical Rationale for Assessing the Impact of Childhood Sexual Abuse on Adjunctive Subcutaneous Esketamine for Treatment-Resistant Depression
title_full A Clinical Rationale for Assessing the Impact of Childhood Sexual Abuse on Adjunctive Subcutaneous Esketamine for Treatment-Resistant Depression
title_fullStr A Clinical Rationale for Assessing the Impact of Childhood Sexual Abuse on Adjunctive Subcutaneous Esketamine for Treatment-Resistant Depression
title_full_unstemmed A Clinical Rationale for Assessing the Impact of Childhood Sexual Abuse on Adjunctive Subcutaneous Esketamine for Treatment-Resistant Depression
title_sort clinical rationale for assessing the impact of childhood sexual abuse on adjunctive subcutaneous esketamine for treatment-resistant depression
publisher Frontiers Media S.A.
series Frontiers in Psychiatry
issn 1664-0640
publishDate 2021-08-01
description Background: A history of child sexual abuse (CSA) is related to higher suicide rates and poor treatment outcomes in depressed adult patients. Twenty years after the first study investigating the effects of ketamine/esketamine on depression and suicide, there is a lack of data on the CSA effects on this emerging treatment. Here, we assess the impact of CSA on adjunctive subcutaneous (SC) esketamine for treatment-resistant depression (TRD).Methods: A directed acyclic graphic (DAG) was designed to identify clinical confounders between CSA and esketamine predictors of response. The confounders were applied in a statistical model to predict depression symptom trajectory in a sample of 67 TRD outpatients.Results: The patient sample had a relatively high prevalence rate of CSA (35.82%). Positive family history of first-degree relatives with alcohol use disorder and sex were clinical mediators of the effects of esketamine in a CSA adult population. Overall, the presence of at least one CSA event was unrelated to esketamine symptom reduction.Conclusions: Unlike responses to conventional antidepressants and psychotherapy, CSA does not appear to predict poor response to esketamine.
topic child sex abuse
treatment-resistant depression
esketamine
sex
directed acyclic graph
url https://www.frontiersin.org/articles/10.3389/fpsyt.2021.608499/full
work_keys_str_mv AT eduardojorgemunizmagalhaes aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT lucianamariasarin aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT lorenacatarinadelsant aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT anacecilialucchese aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT carolinanakahira aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT marcoaureliotuena aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT camilabritopuertas aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT victoraugustorodovalhofava aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT rodrigosimoninidelfino aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT rodrigosimoninidelfino aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT julianasurjan aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT julianasurjan aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT matheussouzasteglich aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT matheussouzasteglich aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT matheusghossainbarbosa aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT guilhermeabdo aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT josealbertodelporto aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT josealbertodelporto aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT charlesbnemeroff aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT hugocogomoreira aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT hugocogomoreira aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT aciolyluiztavareslacerda aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT aciolyluiztavareslacerda aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT aciolyluiztavareslacerda aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT aciolyluiztavareslacerda aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT andreafeijomello aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT andreafeijomello aclinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT eduardojorgemunizmagalhaes clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT lucianamariasarin clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT lorenacatarinadelsant clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT anacecilialucchese clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT carolinanakahira clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT marcoaureliotuena clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT camilabritopuertas clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT victoraugustorodovalhofava clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT rodrigosimoninidelfino clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT rodrigosimoninidelfino clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT julianasurjan clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT julianasurjan clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT matheussouzasteglich clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT matheussouzasteglich clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT matheusghossainbarbosa clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT guilhermeabdo clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT josealbertodelporto clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT josealbertodelporto clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT charlesbnemeroff clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT hugocogomoreira clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT hugocogomoreira clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT aciolyluiztavareslacerda clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT aciolyluiztavareslacerda clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT aciolyluiztavareslacerda clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT aciolyluiztavareslacerda clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT andreafeijomello clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
AT andreafeijomello clinicalrationaleforassessingtheimpactofchildhoodsexualabuseonadjunctivesubcutaneousesketaminefortreatmentresistantdepression
_version_ 1721205467822161920
spelling doaj-b9638f2dcfc5465186e6869dc8fd3f862021-08-17T06:14:49ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402021-08-011210.3389/fpsyt.2021.608499608499A Clinical Rationale for Assessing the Impact of Childhood Sexual Abuse on Adjunctive Subcutaneous Esketamine for Treatment-Resistant DepressionEduardo Jorge Muniz Magalhães0Luciana Maria Sarin1Lorena Catarina Del Sant2Ana Cecília Lucchese3Carolina Nakahira4Marco Aurélio Tuena5Camila Brito Puertas6Victor Augusto Rodovalho Fava7Rodrigo Simonini Delfino8Rodrigo Simonini Delfino9Juliana Surjan10Juliana Surjan11Matheus Souza Steglich12Matheus Souza Steglich13Matheus Ghossain Barbosa14Guilherme Abdo15José Alberto Del Porto16José Alberto Del Porto17Charles B. Nemeroff18Hugo Cogo-Moreira19Hugo Cogo-Moreira20Acioly Luiz Tavares Lacerda21Acioly Luiz Tavares Lacerda22Acioly Luiz Tavares Lacerda23Acioly Luiz Tavares Lacerda24Andrea Feijo Mello25Andrea Feijo Mello26Department of Psychiatry, Federal University of São Paulo, São Paulo, BrazilDepartment of Psychiatry, Federal University of São Paulo, São Paulo, BrazilDepartment of Psychiatry, Federal University of São Paulo, São Paulo, BrazilDepartment of Psychiatry, Federal University of São Paulo, São Paulo, BrazilDepartment of Psychiatry, Federal University of São Paulo, São Paulo, BrazilDepartment of Psychiatry, Federal University of São Paulo, São Paulo, BrazilDepartment of Psychiatry, Federal University of São Paulo, São Paulo, BrazilDepartment of Psychiatry, Federal University of São Paulo, São Paulo, BrazilDepartment of Psychiatry, Federal University of São Paulo, São Paulo, BrazilProgram for Care on Affective Disorders, Department of Psychiatry, Federal University of São Paulo, São Paulo, BrazilDepartment of Psychiatry, Federal University of São Paulo, São Paulo, BrazilProgram for Care on Affective Disorders, Department of Psychiatry, Federal University of São Paulo, São Paulo, BrazilDepartment of Psychiatry, Federal University of São Paulo, São Paulo, BrazilProgram for Care on Affective Disorders, Department of Psychiatry, Federal University of São Paulo, São Paulo, BrazilDepartment of Psychiatry, Federal University of São Paulo, São Paulo, BrazilDepartment of Psychiatry, Federal University of São Paulo, São Paulo, BrazilDepartment of Psychiatry, Federal University of São Paulo, São Paulo, BrazilProgram for Care on Affective Disorders, Department of Psychiatry, Federal University of São Paulo, São Paulo, BrazilDepartment of Psychiatry and Behavioral Sciences, Institute of Early Life Adversity Research, Dell Medical School, University of Texas at Austin, Austin, TX, United StatesDepartment of Psychiatry, Federal University of São Paulo, São Paulo, BrazilDepartment of Education, ICT and Learning, Faculty of Teacher Education and Languages, Østfold University College, Halden, NorwayDepartment of Psychiatry, Federal University of São Paulo, São Paulo, BrazilProgram for Care on Affective Disorders, Department of Psychiatry, Federal University of São Paulo, São Paulo, BrazilLaboratory of Integrative Neuroscience, Department of Psychiatry, Federal University of São Paulo, São Paulo, BrazilCNS Unit, BR Trials, São Paulo, BrazilDepartment of Psychiatry, Federal University of São Paulo, São Paulo, BrazilProgram for Research and Care on Violence and Post-traumatic Stress Disorder, Department of Psychiatry, Federal University of São Paulo, São Paulo, BrazilBackground: A history of child sexual abuse (CSA) is related to higher suicide rates and poor treatment outcomes in depressed adult patients. Twenty years after the first study investigating the effects of ketamine/esketamine on depression and suicide, there is a lack of data on the CSA effects on this emerging treatment. Here, we assess the impact of CSA on adjunctive subcutaneous (SC) esketamine for treatment-resistant depression (TRD).Methods: A directed acyclic graphic (DAG) was designed to identify clinical confounders between CSA and esketamine predictors of response. The confounders were applied in a statistical model to predict depression symptom trajectory in a sample of 67 TRD outpatients.Results: The patient sample had a relatively high prevalence rate of CSA (35.82%). Positive family history of first-degree relatives with alcohol use disorder and sex were clinical mediators of the effects of esketamine in a CSA adult population. Overall, the presence of at least one CSA event was unrelated to esketamine symptom reduction.Conclusions: Unlike responses to conventional antidepressants and psychotherapy, CSA does not appear to predict poor response to esketamine.https://www.frontiersin.org/articles/10.3389/fpsyt.2021.608499/fullchild sex abusetreatment-resistant depressionesketaminesexdirected acyclic graph